Highly Pathogenic Avian Influenza (HPAI) H5N1 detected
• A highly pathogenic strain of avian influenza (HPAI H5N1, clade 2.3.4.4b) has been spreading around the globe since 2020, impacting poultry and wildlife.
• Australian authorities confirmed detection of this strain of HPAI H5N1 in three migratory wild birds in southern Western Australia and South Australia.
• The risk of H5N1 in NZ remains low.
HPV Vaccination delivery update from 1 July 2026
Health New Zealand I Te Whatu Ora has announced an important change to how human papillomavirus (HPV) vaccination will be delivered through the School Based Immunisation Programme from this month.
From 27 July 2026, children will be offered one dose of the HPV vaccine (Gardasil9) at school, with parent or caregiver consent. HPV dose 2 will no longer be offered in schools from this date.
The approved HPV vaccination course in New Zealand is currently two doses for children aged 9 to 14 years. However, international studies show that a single dose provides 97-98% protection against HPV infection and HPV-related cancers.
Based on this evidence, the World Health Organization now recommends a single-dose HPV vaccination schedule. Many countries, including Australia and the United Kingdom, have already adopted this approach.
Note, a second HPV dose remains free and available through GPs, pharmacies and community health providers at least six months after the first dose, should it be requested by whānau.
This change will enable schools to prioritise increasing the uptake of HPV dose 1 (which is currently low) and other catch-up immunisations to address existing immunity gaps and maximise the impact of the programme.
Click here for more information, including the role of primary care in the HPV programme change.
IMAC runs an HPV course for health professionals.
Click here for more information and to register.
HbA1c diagnostic thresholds for prediabetes and diabetes have changed
Click here to view the special report by diabetologist Dr Ryan Paul that outlines the new HbA1c diagnostic thresholds for prediabetes and diabetes that came into effect on 1 July 2026. These changes support the earlier detection and treatment of type 2 diabetes and align New Zealand with international standards.